Publication Name	World Journal of Cardiology
Manuscript ID	47244
Country	Canada

Received	2019-03-11 08:43
Peer-Review Started	2019-03-12 01:22
To Make the First Decision	2019-06-13 02:16
Return for Revision	2019-06-17 02:01
Revised	2019-06-17 19:20
Second Decision	2019-08-29 00:38
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2019-09-25 15:56
Articles in Press	2019-09-25 15:56
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2019-10-24 06:32
Publish the Manuscript Online	2019-10-25 09:37

ISSN	1949-8462 (online)
Open Access	This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Cell Biology
Manuscript Type	Review
Article Title	Cellular models for human cardiomyopathy: What is the best option?
Manuscript Source	Invited Manuscript
All Author List	Nerea Jimenez-Tellez and Steven Clive Greenway
ORCID	Author(s) ORCID Number Nerea Jimenez-Tellez http://orcid.org/0000-0001-8898-2165 Steven Clive Greenway http://orcid.org/0000-0002-6981-1720
Funding Agency and Grant Number	Funding Agency Grant Number Children’s Cardiomyopathy Foundation
Corresponding Author	Steven Clive Greenway, FRCP (C), MD, MSc, Assistant Professor, Staff Physician, Departments of Pediatrics, Cardiac Sciences, Biochemistry & Molecular Biology, Cumming School of Medicine, Libin Cardiovascular Institute of Alberta, Alberta Children’s Hospital Research Institute, University of Calgary, Calgary T2N 4N1, AB, Canada. steven.greenway@ahs.ca
Key Words	Cardiomyopathy; Mitochondria; Induced pluripotent stem cells; Fibroblasts; Cellular models;
Core Tip	Several experimental model systems exist for the modeling of cardiomyopathies, including those caused by rare metabolic or mitochondrial diseases. We compare and contrast the cellular models that have been used to date to model several different mitochondrial disorders with a particular focus on the advantages and disadvantages of induced pluripotent stem cells.
Publish Date	2019-10-25 09:37
Citation	Jimenez-Tellez N, Greenway SC. Cellular models for human cardiomyopathy: What is the best option? World J Cardiol 2019; 11(10):221-235
URL	https://www.wjgnet.com/1949-8462/full/v11/i10/221.htm
DOI	https://dx.doi.org/10.4330/wjc.v11.i10.221

Full Article (PDF)	WJC-11-221.pdf
Full Article (Word)	WJC-11-221.docx
Manuscript File	47244-Review.docx
Answering Reviewers	47244-Answering reviewers.pdf
Audio Core Tip	47244-Audio core tip.wav
Conflict-of-Interest Disclosure Form	47244-Conflict-of-interest statement.pdf
Copyright License Agreement	47244-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	47244-Grant application form(s).pdf
Peer-review Report	47244-Peer-review(s).pdf
Scientific Misconduct Check	47244-Scientific misconduct check.pdf
Scientific Editor Work List	47244-Scientific editor work list.pdf
CrossCheck Report	47244-CrossCheck report.pdf